Index/Topics/Guideline recommendations for PSA monitoring

Guideline recommendations for PSA monitoring

Guideline recommendations for PSA monitoring after prostatectomy

Fact-Checks

5 results
Jan 18, 2026
Most Viewed

How does PSA density measured by MRI compare with TRUS‑based PSAD for predicting clinically significant prostate cancer?

PSA density calculated from MRI-derived prostate volume (MRI‑PSAD or mPSAD) generally outperforms PSAD derived from transrectal ultrasound (TRUS‑PSAD) for predicting clinically significant prostate ca...

Jan 21, 2026
Most Viewed

How long after acute bacterial prostatitis does PSA return to baseline?

reliably raises serum PSA, but the time for PSA to fall back to a patient’s baseline is variable in the literature — typically weeks rather than days; most authoritative reviews and guidelines advise ...

Feb 2, 2026

How is residual benign prostate tissue detected after prostate surgery (PSA, imaging, biopsy)?

after relies on a combination of blood testing, advanced imaging, and targeted tissue sampling: prompt investigation, characterizes suspicious post‑surgical tissue, and provides histologic confirmatio...

Jan 27, 2026

How should clinicians distinguish PSA elevation from prostatitis versus prostate cancer in men over 50?

Clinicians distinguish from versus by integrating clinical context (symptoms and signs of infection), PSA magnitude and dynamics (absolute level and velocity), adjunctive laboratory metrics (free-to-t...

Jan 16, 2026

How do nomograms combine Gleason score, PSA/PSADT, and margin status to estimate individual metastasis risk after prostatectomy?

Nomograms are multivariable statistical tools that combine pathological and biochemical features—most commonly Gleason score, PSA level or PSA doubling time (PSADT), and surgical margin status—to gene...